Pilot Introduction of the Modified Bivalent Killed Whole Cell Oral Cholera Vaccine in Orissa.

Trial Profile

Pilot Introduction of the Modified Bivalent Killed Whole Cell Oral Cholera Vaccine in Orissa.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Feb 2017

At a glance

  • Drugs Cholera vaccine inactivated (Primary)
  • Indications Cholera
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Mar 2012 Planned end date changed from 1 Feb 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.
    • 29 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 08 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top